SG Americas Securities
AMPE

SG Americas Securities’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

SG Americas Securities’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-75
Closed -$13K – 3626
2021
Q4 		$13K Sell
75
-154
-67% -$57.4K ﹤0.01% 3275
2021
Q3 		$114K Buy
+229
New +$106K ﹤0.01% 3606
2020
Q4 		– Sell
-36
Closed -$10K – 3534
2020
Q3 		$10K Buy
+36
New +$8.92K ﹤0.01% 2592
2019
Q2 		– Sell
-41
Closed -$7K – 3546
2019
Q1 		$7K Buy
+41
New +$7.02K ﹤0.01% 3308
2016
Q4 		– Sell
-268
Closed -$60K – 3566
2016
Q3 		$60K Buy
268
+232
+644% +$65.1K ﹤0.01% 3163
2016
Q2 		$14K Buy
+36
New +$39.3K ﹤0.01% 2525
2014
Q2 		– Sell
-71
Closed -$135K – 2758
2014
Q1 		$135K Buy
+71
New +$168K ﹤0.01% 2099

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

SG Americas Securities's AMPE Position: Q1 2022 in Review

SG Americas Securities sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2022, closing a stake of 75 shares — an estimated $13K sold.

SG Americas Securities first reported a position in AMPE in Q1 2014 and held it in 7 quarters. The position peaked at $135K in Q1 2014. 128 funds tracked by Wall St. Rank hold AMPE as of Q1 2022.

  • SG Americas Securities reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2022 after selling out during the quarter.
  • SG Americas Securities sold 75 Ampio Pharmaceuticals Inc. shares in Q1 2022, an estimated $13K.
  • SG Americas Securities first reported a position in Ampio Pharmaceuticals Inc. in Q1 2014 and held it in 7 quarters.
  • SG Americas Securities's Ampio Pharmaceuticals Inc. position peaked at $135K in Q1 2014.
  • 128 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2022.

Based on SG Americas Securities's 13F filing for Q1 2022, filed 29 Apr 2022.